asundexian,finerenone
bayer
['factor xi', 'asundexian', 'kerendia', 'bayer']
just after reporting disappointing results for the factor xia inhibitor asundexian, bayer said its approved med kerendia also didn t reach significance on all-cause mortality in a pooled analysis of two phase iii trials of the drug. #esc22 
The biopharma world is here. Get the industry’s most comprehensive daily news report at https://t.co/rXFyNyZcJs